John Hyngstrom

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Sapna P. Patel, Megan Othus, Yuanbin Chen et al. · New England Journal of Medicine · 2023 · 827 citations · Full text

Medicine, Oncology, Surgery +17

Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base

John Hyngstrom, Chung-Yuan Hu, Yan Xing et al. · Annals of Surgical Oncology · 2012 · 351 citations · Full text

Medicine, Oncology, Pathology +14

Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

Jason Chesney, Antoni Ribas, Georgina V. Long et al. · Journal of Clinical Oncology · 2022 · 284 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial

Reinhard Dummer, David Gyorki, John Hyngstrom et al. · Nature Medicine · 2021 · 148 citations

Medicine, Oncology, Surgery +14

Cardiac, skeletal, and smooth muscle mitochondrial respiration: are all mitochondria created equal?

Song-Young Park, Jayson R. Gifford, Robert H.I. Andtbacka et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2014 · 127 citations · Full text

Life Sciences, Biochemistry, Physiology +16